| dc.contributor.author | Rodriguez-Morales, A.J. | |
| dc.contributor.author | Abbara, A. | |
| dc.contributor.author | Ntoumi, F. | |
| dc.contributor.author | Kapata, N. | |
| dc.contributor.author | Mwaba, P. | |
| dc.contributor.author | Yeboah-Manu, D. | |
| dc.contributor.author | Maeurer, M. | |
| dc.contributor.author | Dar, O. | |
| dc.contributor.author | Abubakar, I. | |
| dc.contributor.author | Zumla, A. | |
| dc.date.accessioned | 2025-10-31T18:32:33Z | |
| dc.date.available | 2025-10-31T18:32:33Z | |
| dc.date.issued | 2023 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12805/4693 | |
| dc.description.abstract | World Tuberculosis (TB) Day, March 24th, 2023, will commemorate the day in 1882 when Professor Robert Koch announced his discovery of Mycobacterium tuberculosis (Mtb) when TB ravaged Europe. Over a century later, in 1993, the World Health Organization (WHO) declared TB a global health emergency. Since then, there have been 60 million deaths due to TB. The tragic state of affairs reflects a great paradox – that, despite affordable and effective TB treatment being available for the past seven decades, the latest 2022 WHO Annual Global Tuberculosis Report highlights that TB remains a leading cause of ill health and death from an infectious disease worldwide... | en_US |
| dc.description.sponsorship | IA, FN, DYM, NK, OD, PM and AZ acknowledge support from the EU European & Developing Countries Clinical Trials Partnership-funded Pan-African Network for Rapid Research, Response, Relief and Preparedness for infectious diseases epidemics (PANDORA-ID-NET) , Central African Network on Tuberculosis, HIV/AIDS and Malaria (CANTAM-3) , and East African Consortium for Clinical Research (EACCR3) programmes. IA acknowledges support from a UK NIHR Senior Investigator Award and an NIHR Programme Grant (RID-TB) . AZ receives a UK National Institutes for Health Research Senior Investigator award and is a Mahathir Foundation Science Award and Pascoal Mocumbi Prize laureate . All other authors declare no competing interests. The views expressed in this Editorial are entirely those of the authors and do not reflect the opinions of their respective institutions. | |
| dc.format | application/pdf | |
| dc.language.iso | eng | |
| dc.publisher | Elsevier | |
| dc.relation.ispartof | urn:issn:1477-8939 | |
| dc.rights | https://purl.org/coar/access_right/c_abf2 | |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/4.0/ | |
| dc.subject | SDG 3 | en_US |
| dc.subject | Tuberculosis Treatment and Diagnostic Innovations | en_US |
| dc.subject | Health Challenges of Migrants with Tuberculosis | en_US |
| dc.title | World tuberculosis day 2023 – Reflections on the spread of drug-resistant tuberculosis by travellers and reducing risk in forcibly displaced populations | en_US |
| dc.type | https://purl.org/coar/resource_type/c_b239 | |
| dc.identifier.doi | https://doi.org/10.1016/j.tmaid.2023.102568 | |
| dc.subject.ocde | https://purl.org/pe-repo/ocde/ford#3.03.08 | |
| dc.type.other | Editorial | |
| dc.identifier.journal | Travel Medicine and Infectious Disease | |
| dc.type.version | https://purl.org/coar/version/c_970fb48d4fbd8a85 | |